LIP
LXRX icon

Lighthouse Investment Partners’s Lexicon Pharmaceuticals LXRX Stock Holding History

Lighthouse Investment Partners’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-126,600
Closed -$146K – 912
2025
Q4 		$146K Buy
+126,600
New +$174K ﹤0.01% 780

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Lighthouse Investment Partners's LXRX Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2026, closing a stake of 126,600 shares — an estimated $146K sold.

Lighthouse Investment Partners first reported a position in LXRX in Q4 2025 and held it in 1 quarter. The position peaked at $146K in Q4 2025. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining Lexicon Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 126,600 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $146K.
  • Lighthouse Investment Partners first reported a position in Lexicon Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Lighthouse Investment Partners's Lexicon Pharmaceuticals position peaked at $146K in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.